We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

8 hedge funds and large institutions have $67.8K invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

86% less funds holding

Funds holding: 58 → 8 (-50)

99% less capital invested

Capital invested by funds: $8.73M → $67.8K (-$8.66M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
8
Holders Change
-50
Holders Change %
-86.21%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SWM
Spire Wealth Management
Virginia
+$56.8K
2
XT
XTX Topco
Cayman Islands
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.15M
2
BlackRock
BlackRock
New York
-$1.88M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.73M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$630K
5
State Street
State Street
Massachusetts
-$573K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
1
Spire Wealth Management
Virginia
$40.4K +$56.8K +152,807 +1,704%
XT
2
XTX Topco
Cayman Islands
$16.7K +$17.9K +48,248 +256%
CGL
3
Clarius Group LLC
Washington
$4.99K – – –
GT
4
Glenmede Trust
Pennsylvania
$4.78K – – –
Osaic Holdings
5
Osaic Holdings
Arizona
$596 -$1.95K -5,250 -69%
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
$206 – – –
RF
7
Robinswood Financial
Washington
$13 – – –
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
– -$2.15M -3,000,000 Closed
BlackRock
9
BlackRock
New York
– -$1.88M -2,623,052 Closed
Vanguard Group
10
Vanguard Group
Pennsylvania
– -$1.73M -2,411,679 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$630K -878,543 Closed
State Street
12
State Street
Massachusetts
– -$573K -799,273 Closed
Northern Trust
13
Northern Trust
Illinois
– -$239K -333,250 Closed
Creative Planning
14
Creative Planning
Kansas
– -$206K -286,862 Closed
BCM
15
Bridgeway Capital Management
Texas
– -$164K -229,100 Closed
Pathstone Holdings
16
Pathstone Holdings
New Jersey
– -$110K -153,846 Closed
SAS
17
Stelac Advisory Services
New York
– -$101K -140,402 Closed
Charles Schwab
18
Charles Schwab
California
– -$86.3K -120,334 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$78.9K -110,015 Closed
Bank of America
20
Bank of America
North Carolina
– -$66K -91,981 Closed
IC
21
IEQ Capital
California
– -$59.7K -83,262 Closed
ML
22
McAdam LLC
Pennsylvania
– -$56.2K -78,281 Closed
Morgan Stanley
23
Morgan Stanley
New York
– -$44.6K -62,229 Closed
N
24
Nuveen
North Carolina
– -$41.6K -58,029 Closed
Millennium Management
25
Millennium Management
New York
– -$34.6K -48,194 Closed
1
2 3

VAXX Hedge Fund Activity: Q2 2024 in Review

8 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2024, worth a combined $67.8K — down 99% from $8.73M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of VAXX and 0 opened new positions — a net loss of 50 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Spire Wealth Management, adding an estimated $56.8K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $2.15M sold.

  • 8 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2024, down from 58 in Q1 2024.
  • Funds reported $67.8K of Vaxxinity, Inc. Class A Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2024 and 50 closed out, a net change of -50 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2024 was Spire Wealth Management, an estimated $56.8K added.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2024 was Adage Capital Partners, an estimated $2.15M sold.

Based on aggregated 13F filings for Q2 2024.